LetterSkin metastases of leiomyosarcoma (LMS): A retrospective review of 21 cases
References (4)
- et al.
Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes
J Am Acad Dermatol
(2014) - et al.
Cutaneous metastasis of leiomyosarcoma
Dermatol Surg
(2007)
There are more references available in the full text version of this article.
Cited by (11)
Rapidly growing asymptomatic violaceous nodule
2021, JAAD Case ReportsCutaneous leiomyosarcoma: a 20-year retrospective study and review of the literature
2021, Anais Brasileiros de DermatologiaCitation Excerpt :Dermal leiomyosarcomas seem to arise from dermal piloerector smooth muscle.3 This type of leiomyosarcomas generally behaves as a non-aggressive neoplasm, with a relative tendency to local recurrence after removal (24%) but with a low risk of distant metastasis (3%–14%).1,4,5 On the other hand, subcutaneous leiomyosarcomas derive from smooth muscle fibers of the middle layer of the vascular wall of arteries and veins.3
Cutaneous Sarcomas
2019, Hematology/Oncology Clinics of North AmericaCitation Excerpt :Patients with superficial LMS require close follow-up. Average time to LMS metastasis is 5.6 years, with disease-specific mortality of dermal LMS of 6% and 40% for subcutaneous LMS.76 Close follow-up for at least 5 to 10 years after diagnosis is recommended.66
Clinical and Histopathologic Findings of Cutaneous Leiomyosarcoma: Correlation with Prognosis in 12 Patients
2018, Actas Dermo-SifiliograficasCutaneous Leiomyosarcoma: On the Importance of Histologic Location
2018, Actas Dermo-Sifiliograficas
Funding sources: None.
Conflicts of interest: None declared.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.